Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Board Changes

9 Jul 2020 14:28

RNS Number : 5819S
B&M European Value Retail S.A.
09 July 2020
 

 

 

9 July 2020 

B&M European Value Retail S.A.

Board Changes

 

B&M European Value Retail S.A. (the "Company") announces that, further to the announcement made on 3 March 2020, Alex Russo will join the Company as the Chief Financial Officer ("CFO") Designate on 5 October 2020. Alex will be appointed as an Executive Director and Chief Financial Officer ("CFO") of the Company on 16 November 2020 following a handover period with Paul McDonald.

 

Paul McDonald will retire from the Board of Directors of the Company on 15 November 2020 but will remain employed by the Company under garden leave and remain able to assist the group as required for the remainder of his notice period to 8 January 2021.

 

Peter Bamford, Chairman, said:

 "I am delighted that Alex Russo will be joining the Board of B&M later this year. His previous roles with leading retail businesses in the UK and internationally brings a valuable level of experience to the Board as our business continues to grow at a significant rate. Paul McDonald has done an excellent job as CFO for the last nine years and we thank him for his contribution and wish him well for the future."

 

In respect of Paul McDonald's remuneration the Company confirms that the following financial terms below have been agreed with Paul in line with the Company's Remuneration Policy which was approved by the shareholders at the 2018 AGM:

 

1. he will continue to receive salary and benefits up to the expiry of his notice period to 8 January 2021;

 

2. he will participate in the 2020/21 annual incentive bonus plan ("AIP"), on a pro-rata basis (excluding the period of garden leave), subject to the determination by the Remuneration Committee of the outcome of the performance conditions following the financial year end. One-third of any bonus will be subject to deferral into shares in the normal way;

 

3. as a good leaver his outstanding awards under the Long Term Incentive Plan ("LTIP") made in 2018 and 2019 will vest to the extent that the performance conditions are met, pro-rated proportionately to his actual period of service (excluding the period of garden leave);

 

4. LTIP awards in respect of which the performance conditions have already been satisfied, which were made in 2015, 2016 and 2017, will be exercisable by him when the holding periods for those awards have expired;

 

5. his Deferred Bonus Share Plan ("DBSP") awards (including any to be awarded on the outturn of the 2020/21 AIP bonus) will vest and become exercisable on the expiry of the normal vesting periods in relation to those awards; and

 

6. he will not receive an LTIP grant in 2020/21 and no compensation for loss of office will be payable.

 

All AIP, LTIP or DBSP awards which include malus and clawback provisions under their respective plan rules will continue to apply.

 

Details of Paul McDonald's remuneration will be disclosed in the Directors' Remuneration Report for 2020/21 and the vesting of share awards in subsequent years as applicable.

 

Enquiries

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Daniel Yea

bmstores-maitland@maitland.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABXGDRLDGDGGC
Date   Source Headline
2nd Nov 202212:06 pmRNSConfirmation of timing of Interim Results
31st Oct 20229:23 amRNSAppointment of directors- Result of Meeting
18th Oct 20223:51 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSNotice of GM
15th Sep 20228:20 amRNSManagement Succession and Board Update
9th Sep 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20223:06 pmRNSDirector/PDMR Shareholding
31st Aug 20223:01 pmRNSTotal Voting Rights
18th Aug 20227:00 amRNSBoard Appointment and Retirement
5th Aug 20224:41 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSAppointment of Joint Corporate Broker
3rd Aug 202212:12 pmRNSTR1 Notification
29th Jul 202210:28 amRNSAGM Voting Results
14th Jul 202212:07 pmRNSBlock Listing Application
13th Jul 20223:48 pmRNSBlock listing Interim Review
5th Jul 20227:00 amRNSBoard appointment
29th Jun 20227:00 amRNSQ1 FY23 Trading Update
21st Jun 20227:00 amRNSAnnual Financial Report and Notice of AGM
16th Jun 20229:55 amRNSHolding(s) in Company
9th Jun 20221:17 pmRNSHolding(s) in Company
9th Jun 202212:16 pmRNSDirector/PDMR grant of options
8th Jun 20227:00 amRNSDirector/PDMR Notice
31st May 20227:01 amRNSFY22 Preliminary Results
31st May 20227:00 amRNSCEO Succession
22nd Apr 20227:00 amRNSCEO Succession Plan
18th Jan 202211:11 amRNSHolding(s) in Company
18th Jan 202211:01 amRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResult of Secondary Placing of Ordinary Shares
13th Jan 20224:45 pmRNSProposed Secondary Placing of Ordinary Shares
13th Jan 20221:05 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSQ3 FY22 Trading Update
30th Dec 20214:58 pmRNSPost Stabilisation Notice
9th Dec 20217:00 amRNSSpecial Dividend
24th Nov 202111:02 amRNSDirector/PDMR Notice
17th Nov 20213:48 pmRNSPricing of Senior Secured Notes Offering
15th Nov 20218:16 amRNSLaunch of Senior Secured Notes Offering
11th Nov 20217:00 amRNSFY22 Interim Results
10th Nov 20214:19 pmRNSHolding(s) in Company
10th Nov 202111:42 amRNSResult of Ordinary General Meeting
30th Sep 20219:00 amRNSTotal Voting Rights
30th Sep 20219:00 amRNSOrdinary General Meeting
16th Sep 20219:26 amRNSDirector/PDMR Shareholding
8th Sep 20219:36 amRNSTrading Update
12th Aug 20217:00 amRNSBoard Appointment
4th Aug 20218:00 amRNSBlock Listing Application
3rd Aug 202111:12 amRNSDirector/PDMR Shareholding
2nd Aug 202110:32 amRNSTotal Voting Rights
29th Jul 202112:16 pmRNSResult of AGM
20th Jul 202112:35 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.